SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,596,172 | +145.4% | 1,052,600 | +131.9% | 1.96% | +113.4% |
Q2 2023 | $51,992,080 | -35.6% | 454,000 | -22.5% | 0.92% | -41.0% |
Q1 2023 | $80,779,269 | +2.6% | 586,079 | -3.6% | 1.56% | +27.2% |
Q4 2022 | $78,745,766 | +71.1% | 607,700 | +46.0% | 1.23% | +93.7% |
Q3 2022 | $46,018,000 | +102.2% | 416,372 | +37.1% | 0.63% | +101.9% |
Q2 2022 | $22,758,000 | +175.9% | 303,600 | +187.5% | 0.31% | +214.0% |
Q1 2022 | $8,250,000 | -86.1% | 105,600 | -83.9% | 0.10% | -84.9% |
Q4 2021 | $59,208,000 | +1203.9% | 657,500 | +1239.1% | 0.66% | +1176.9% |
Q3 2021 | $4,541,000 | -58.3% | 49,100 | -65.0% | 0.05% | -63.4% |
Q2 2021 | $10,891,000 | -47.9% | 140,100 | +14.4% | 0.14% | -70.2% |
Q4 2020 | $20,885,000 | +41.7% | 122,500 | +16.7% | 0.48% | +38.3% |
Q3 2020 | $14,743,000 | +29.2% | 105,000 | +47.5% | 0.34% | -9.2% |
Q2 2020 | $11,415,000 | -33.8% | 71,200 | -59.6% | 0.38% | -61.0% |
Q1 2020 | $17,237,000 | +5.0% | 176,200 | +38.5% | 0.98% | +77.0% |
Q4 2019 | $16,414,000 | +190.6% | 127,200 | +69.6% | 0.55% | +87.4% |
Q3 2019 | $5,648,000 | -67.1% | 75,000 | -33.6% | 0.29% | -66.0% |
Q2 2019 | $17,155,000 | +234.0% | 112,900 | +161.9% | 0.86% | +205.3% |
Q1 2019 | $5,136,000 | – | 43,100 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |